share_log

Stifel Downgrades Treace Medical Concepts to Hold, Lowers Price Target to $6

Stifel Downgrades Treace Medical Concepts to Hold, Lowers Price Target to $6

Stifel将Treace Medical Concepts的评级下调至持有,将目标股价下调至6美元
Benzinga ·  05/08 06:26

Stifel analyst Rick Wise downgrades Treace Medical Concepts (NASDAQ:TMCI) from Buy to Hold and lowers the price target from $15 to $6.

Stifel分析师里克·怀斯将Treace Medical Concepts(纳斯达克股票代码:TMCI)的评级从买入下调至持有,并将目标股价从15美元下调至6美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发